Cargando…
Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use
Drug-induced interstitial lung disease is a rare condition attributed to several medications, including antimicrobial agents such as amphotericin B, anti-inflammatory agents such as methotrexate, biologic agents such as bevacizumab, and cardiovascular agents and chemotherapeutic agents. We describe...
Autores principales: | Rambaran, Kerry Anne, Seifert, Charles F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078134/ https://www.ncbi.nlm.nih.gov/pubmed/27778245 http://dx.doi.org/10.1007/s40800-016-0037-5 |
Ejemplares similares
-
Nitrofurantoin: Interstitial lung disease: case report
Publicado: (2021) -
Nitrofurantoin induced interstitial lung disease
por: Naidu, G. D., et al.
Publicado: (2014) -
Reversible interstitial lung disease with prolonged use of nitrofurantoin: Do the benefits outweigh the risks?
por: Singh, Akashdeep, et al.
Publicado: (2013) -
Nitrofurantoin-Associated Acute Granulomatous Interstitial
Nephritis
por: Anupama, B. K., et al.
Publicado: (2021) -
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
por: Carvalho de Matos, Andreia, et al.
Publicado: (2021)